Cefazolin
- Product NDC
- 84549-142
- 11-digit product format
- 845490142
- Labeler code
- 84549
- Product ID
- 84549-142_3d5cc73c-8a42-b285-e063-6294a90a609f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cefazolin
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- ProPharma Distribution
- Application
- ANDA203661
- Marketing category
- ANDA
- Marketing start
- 2017-06-30
- Substance
- CEFAZOLIN SODIUM
- Active strength
- 1 g/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A203661-001 | CEFAZOLIN SODIUM | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2015-12-28 | |
| A203661-002 | CEFAZOLIN SODIUM | CEFAZOLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2022-03-11 | ||
| A203661-003 | CEFAZOLIN SODIUM | CEFAZOLIN SODIUM | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | 2024-01-24 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A203661-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A203661-001 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2015-12-28 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A203661-002 | CEFAZOLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2022-03-11 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A203661-003 | CEFAZOLIN SODIUM | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | 2024-01-24 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A203661-001 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2015-12-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A203661-002 | CEFAZOLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2022-03-11 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A203661-003 | CEFAZOLIN SODIUM | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | 2024-01-24 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A203661-001 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2015-12-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A203661-002 | CEFAZOLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2022-03-11 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A203661-003 | CEFAZOLIN SODIUM | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | 2024-01-24 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A203661-001 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2015-12-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A203661-002 | CEFAZOLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2022-03-11 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A203661-003 | CEFAZOLIN SODIUM | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | 2024-01-24 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203661-001 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2015-12-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203661-002 | CEFAZOLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2022-03-11 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203661-003 | CEFAZOLIN SODIUM | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | 2024-01-24 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A203661-001 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2015-12-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A203661-002 | CEFAZOLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2022-03-11 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A203661-003 | CEFAZOLIN SODIUM | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | 2024-01-24 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203661-001 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2015-12-28 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203661-002 | CEFAZOLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2022-03-11 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203661-003 | CEFAZOLIN SODIUM | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | 2024-01-24 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203661-001 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2015-12-28 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203661-002 | CEFAZOLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2022-03-11 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203661-003 | CEFAZOLIN SODIUM | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | 2024-01-24 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203661-001 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2015-12-28 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203661-002 | CEFAZOLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2022-03-11 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203661-003 | CEFAZOLIN SODIUM | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | 2024-01-24 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203661-001 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2015-12-28 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203661-002 | CEFAZOLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2022-03-11 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203661-003 | CEFAZOLIN SODIUM | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | 2024-01-24 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203661-001 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2015-12-28 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203661-002 | CEFAZOLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2022-03-11 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203661-003 | CEFAZOLIN SODIUM | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | 2024-01-24 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203661-001 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2015-12-28 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203661-002 | CEFAZOLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2022-03-11 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203661-003 | CEFAZOLIN SODIUM | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | 2024-01-24 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A203661-001 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2015-12-28 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A203661-002 | CEFAZOLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2022-03-11 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A203661-003 | CEFAZOLIN SODIUM | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | 2024-01-24 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203661-001 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2015-12-28 | 79d66fd596c7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A203661-001 | AP | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A203661-001 | AP | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A203661-001 | AP | 1 | cb3db0bc1861… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A203661-001 | AP | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cefazolin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CEFAZOLIN SODIUM | 1 g/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| P380M0454Z | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1665050 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3d5cc73c-8a41-b285-e063-6294a90a609f | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 4c53c44d-0495-40c1-9f02-9d772dc7a5c7 | Product name | 1 | 20250318 |
| 53d47d5d-6076-4275-8f76-06d261cff1e8 | Product name | 1 | 20231011 |
| 9afe2d9a-f7f6-416b-9ddf-b780a2810bd5 | Product name | 1 | 20230912 |
| 6e62eeca-6666-f31f-9873-48ea9ede8354 | Product name | 2 | 20190214 |
| afa25392-d76e-4453-8841-fde3a34824f1 | Product name | 2 | 20160309 |
| 53cae805-773b-4bc5-a836-3e22e250892e | Product name | 1 | 20150922 |
| 05d4c919-c877-4ec4-cb08-9fcbbbfd8c70 | Product name | 1 | 20140508 |
| 75ba2549-0297-c880-16c8-4fa502c95a9d | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84549-142-05 | Cefazolin | 1 in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, FOR SOLUTION | 1 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CEFAZOLIN | CEFAZOLIN | Henry Schein, Inc. | 5a8c4bb2-a75e-4d7d-91fb-9a95f04fc94b | 2025-10-27 | Warnings, Adverse reactions | 203661 ANDA203661 |
| Cefazolin | CEFAZOLIN | ProPharma Distribution | 3d5cc73c-8a41-b285-e063-6294a90a609f | 2025-08-27 | Warnings, Adverse reactions | 203661 ANDA203661 84549-142 |
| Cefazolin | CEFAZOLIN | Apotex Corp. | 0422fe47-c372-494f-bac2-612f550b44a4 | 2025-07-15 | Warnings, Adverse reactions | 203661 ANDA203661 |
| Cefazolin Sodium | CEFAZOLIN SODIUM | Direct_rx | 22dfc2e4-07a7-8d13-e063-6394a90a3e9f | 2024-09-24 | Warnings, Adverse reactions | 203661 ANDA203661 |
| Cefazolin | CEFAZOLIN | Qilu Pharmaceutical Co., Ltd. | e8bd9e95-8af5-416b-b58c-e1dbe3d052ac | 2023-12-18 | Warnings, Adverse reactions | 203661 ANDA203661 |
| Cefazolin | CEFAZOLIN | Apotex Corp. | 37a626aa-96dc-4c4d-bfbc-be4f328f918b | 2023-12-15 | Warnings, Adverse reactions | 203661 ANDA203661 |
| Cefazolin | CEFAZOLIN | Medical Purchasing Solutions, LLC | 79787707-c84f-f229-e053-2a91aa0a1f16 | 2023-05-16 | Warnings, Adverse reactions | 203661 ANDA203661 |
| Cefazolin | CEFAZOLIN | Proficient Rx LP | d24529e3-e2b4-46d6-81ba-b7da74501792 | 2022-08-01 | Warnings, Adverse reactions | 203661 ANDA203661 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1665050 | ceFAZolin 1 GM Injection | PSN | 3d5cc73c-8a41-b285-e063-6294a90a609f | 1 |
| 1665050 | cefazolin 1000 MG Injection | SCD | 3d5cc73c-8a41-b285-e063-6294a90a609f | 1 |
| 1665050 | cefazolin 1 GM (as cefazolin sodium) Injection | SY | 3d5cc73c-8a41-b285-e063-6294a90a609f | 1 |
| 1665050 | cefazolin 1 GM Injection | SY | 3d5cc73c-8a41-b285-e063-6294a90a609f | 1 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 84549-142-05 | 84549014205 | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (84549-142-05) | 2025-09-01 | No | No | Current |